Henry Schein Inc (NASDAQ:HSIC)
| 74.40 Delayed Data As of Jun 02 |  +0.97 / +1.32%Today’s Change | 64.75 Today|||52-Week Range 89.72 | -6.85% Year-to-Date |
| SECTOR Distribution Services | INDUSTRY Medical Distributors | MARKET CAP $9.7B |
Company Description
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Contact Information
Henry Schein, Inc. 135 Duryea Road Melville New York 11747 |
Employees
Shareholders
| Mutual fund holders | 56.15% |
| Individual stakeholders | 5.53% |
| Other institutional | 43.79% |
Top Executives
| Stanley M. Bergman | Chairman & Chief Executive Officer |
| James P. Breslawski | Vice Chairman & President |
| Michael Saul Ettinger | Chief Operating Officer & Executive Vice President |
| Ronald N. South | Chief Financial Officer & Senior Vice President |
| Christopher Pendergast | Chief Technology Officer & Senior Vice President |
